These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 36115062)

  • 1. Comprehensive Fragment Screening of the SARS-CoV-2 Proteome Explores Novel Chemical Space for Drug Development.
    Berg H; Wirtz Martin MA; Altincekic N; Alshamleh I; Kaur Bains J; Blechar J; Ceylan B; de Jesus V; Dhamotharan K; Fuks C; Gande SL; Hargittay B; Hohmann KF; Hutchison MT; Marianne Korn S; Krishnathas R; Kutz F; Linhard V; Matzel T; Meiser N; Niesteruk A; Pyper DJ; Schulte L; Trucks S; Azzaoui K; Blommers MJJ; Gadiya Y; Karki R; Zaliani A; Gribbon P; da Silva Almeida M; Dinis Anobom C; Bula AL; Bütikofer M; Putinhon Caruso Í; Caterina Felli I; Da Poian AT; Cardoso de Amorim G; Fourkiotis NK; Gallo A; Ghosh D; Gomes-Neto F; Gorbatyuk O; Hao B; Kurauskas V; Lecoq L; Li Y; Cunha Mebus-Antunes N; Mompeán M; Cristtina Neves-Martins T; Ninot-Pedrosa M; Pinheiro AS; Pontoriero L; Pustovalova Y; Riek R; Robertson AJ; Jose Abi Saad M; Treviño MÁ; Tsika AC; Almeida FCL; Bax A; Henzler-Wildman K; Hoch JC; Jaudzems K; Laurents DV; Orts J; Pierattelli R; Spyroulias GA; Duchardt-Ferner E; Ferner J; Fürtig B; Hengesbach M; Löhr F; Qureshi N; Richter C; Saxena K; Schlundt A; Sreeramulu S; Wacker A; Weigand JE; Wirmer-Bartoschek J; Wöhnert J; Schwalbe H
    Angew Chem Int Ed Engl; 2022 Nov; 61(46):e202205858. PubMed ID: 36115062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR
    Hymon D; Martins J; Richter C; Sreeramulu S; Wacker A; Ferner J; Patwardhan NN; Hargrove AE; Schwalbe H
    RSC Med Chem; 2024 Jan; 15(1):165-177. PubMed ID: 38283228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS-CoV-2 Genome.
    Sreeramulu S; Richter C; Berg H; Wirtz Martin MA; Ceylan B; Matzel T; Adam J; Altincekic N; Azzaoui K; Bains JK; Blommers MJJ; Ferner J; Fürtig B; Göbel M; Grün JT; Hengesbach M; Hohmann KF; Hymon D; Knezic B; Martins JN; Mertinkus KR; Niesteruk A; Peter SA; Pyper DJ; Qureshi NS; Scheffer U; Schlundt A; Schnieders R; Stirnal E; Sudakov A; Tröster A; Vögele J; Wacker A; Weigand JE; Wirmer-Bartoschek J; Wöhnert J; Schwalbe H
    Angew Chem Int Ed Engl; 2021 Aug; 60(35):19191-19200. PubMed ID: 34161644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2.
    Shan H; Liu J; Shen J; Dai J; Xu G; Lu K; Han C; Wang Y; Xu X; Tong Y; Xiang H; Ai Z; Zhuang G; Hu J; Zhang Z; Li Y; Pan L; Tan L
    Cell Chem Biol; 2021 Jun; 28(6):855-865.e9. PubMed ID: 33979649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy.
    Wacker A; Weigand JE; Akabayov SR; Altincekic N; Bains JK; Banijamali E; Binas O; Castillo-Martinez J; Cetiner E; Ceylan B; Chiu LY; Davila-Calderon J; Dhamotharan K; Duchardt-Ferner E; Ferner J; Frydman L; Fürtig B; Gallego J; Grün JT; Hacker C; Haddad C; Hähnke M; Hengesbach M; Hiller F; Hohmann KF; Hymon D; de Jesus V; Jonker H; Keller H; Knezic B; Landgraf T; Löhr F; Luo L; Mertinkus KR; Muhs C; Novakovic M; Oxenfarth A; Palomino-Schätzlein M; Petzold K; Peter SA; Pyper DJ; Qureshi NS; Riad M; Richter C; Saxena K; Schamber T; Scherf T; Schlagnitweit J; Schlundt A; Schnieders R; Schwalbe H; Simba-Lahuasi A; Sreeramulu S; Stirnal E; Sudakov A; Tants JN; Tolbert BS; Vögele J; Weiß L; Wirmer-Bartoschek J; Wirtz Martin MA; Wöhnert J; Zetzsche H
    Nucleic Acids Res; 2020 Dec; 48(22):12415-12435. PubMed ID: 33167030
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Mertinkus KR; Grün JT; Altincekic N; Bains JK; Ceylan B; Ferner JP; Frydman L; Fürtig B; Hengesbach M; Hohmann KF; Hymon D; Kim J; Knezic B; Novakovic M; Oxenfarth A; Peter SA; Qureshi NS; Richter C; Scherf T; Schlundt A; Schnieders R; Schwalbe H; Stirnal E; Sudakov A; Vögele J; Wacker A; Weigand JE; Wirmer-Bartoschek J; Martin MAW; Wöhnert J
    Biomol NMR Assign; 2022 Apr; 16(1):17-25. PubMed ID: 35178672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of kinetics and thermodynamics of interaction between immobilized SARS-CoV-2 nucleoprotein and specific antibodies by total internal reflection ellipsometry.
    Plikusiene I; Maciulis V; Ramanaviciene A; Balevicius Z; Buzavaite-Verteliene E; Ciplys E; Slibinskas R; Simanavicius M; Zvirbliene A; Ramanavicius A
    J Colloid Interface Sci; 2021 Jul; 594():195-203. PubMed ID: 33761394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A COVID moonshot: assessment of ligand binding to the SARS-CoV-2 main protease by saturation transfer difference NMR spectroscopy.
    Kantsadi AL; Cattermole E; Matsoukas MT; Spyroulias GA; Vakonakis I
    J Biomol NMR; 2021 May; 75(4-5):167-178. PubMed ID: 33856612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions.
    Torrens-Fontanals M; Peralta-García A; Talarico C; Guixà-González R; Giorgino T; Selent J
    Nucleic Acids Res; 2022 Jan; 50(D1):D858-D866. PubMed ID: 34761257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening.
    Ma S; Damfo S; Lou J; Pinotsis N; Bowler MW; Haider S; Kozielski F
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COVID19-NMR Consortium: A Public Report on the Impact of this New Global Collaboration.
    Duchardt-Ferner E; Ferner J; Fürtig B; Hengesbach M; Richter C; Schlundt A; Sreeramulu S; Wacker A; Weigand JE; Wirmer-Bartoschek J; Schwalbe H
    Angew Chem Int Ed Engl; 2023 Mar; 62(14):e202217171. PubMed ID: 36748955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
    Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
    J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications.
    Altincekic N; Korn SM; Qureshi NS; Dujardin M; Ninot-Pedrosa M; Abele R; Abi Saad MJ; Alfano C; Almeida FCL; Alshamleh I; de Amorim GC; Anderson TK; Anobom CD; Anorma C; Bains JK; Bax A; Blackledge M; Blechar J; Böckmann A; Brigandat L; Bula A; Bütikofer M; Camacho-Zarco AR; Carlomagno T; Caruso IP; Ceylan B; Chaikuad A; Chu F; Cole L; Crosby MG; de Jesus V; Dhamotharan K; Felli IC; Ferner J; Fleischmann Y; Fogeron ML; Fourkiotis NK; Fuks C; Fürtig B; Gallo A; Gande SL; Gerez JA; Ghosh D; Gomes-Neto F; Gorbatyuk O; Guseva S; Hacker C; Häfner S; Hao B; Hargittay B; Henzler-Wildman K; Hoch JC; Hohmann KF; Hutchison MT; Jaudzems K; Jović K; Kaderli J; Kalniņš G; Kaņepe I; Kirchdoerfer RN; Kirkpatrick J; Knapp S; Krishnathas R; Kutz F; Zur Lage S; Lambertz R; Lang A; Laurents D; Lecoq L; Linhard V; Löhr F; Malki A; Bessa LM; Martin RW; Matzel T; Maurin D; McNutt SW; Mebus-Antunes NC; Meier BH; Meiser N; Mompeán M; Monaca E; Montserret R; Mariño Perez L; Moser C; Muhle-Goll C; Neves-Martins TC; Ni X; Norton-Baker B; Pierattelli R; Pontoriero L; Pustovalova Y; Ohlenschläger O; Orts J; Da Poian AT; Pyper DJ; Richter C; Riek R; Rienstra CM; Robertson A; Pinheiro AS; Sabbatella R; Salvi N; Saxena K; Schulte L; Schiavina M; Schwalbe H; Silber M; Almeida MDS; Sprague-Piercy MA; Spyroulias GA; Sreeramulu S; Tants JN; Tārs K; Torres F; Töws S; Treviño MÁ; Trucks S; Tsika AC; Varga K; Wang Y; Weber ME; Weigand JE; Wiedemann C; Wirmer-Bartoschek J; Wirtz Martin MA; Zehnder J; Hengesbach M; Schlundt A
    Front Mol Biosci; 2021; 8():653148. PubMed ID: 34041264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
    Freidel MR; Armen RS
    PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Bung N; Krishnan SR; Bulusu G; Roy A
    Future Med Chem; 2021 Mar; 13(6):575-585. PubMed ID: 33590764
    [No Abstract]   [Full Text] [Related]  

  • 16. Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.
    Manelfi C; Gossen J; Gervasoni S; Talarico C; Albani S; Philipp BJ; Musiani F; Vistoli G; Rossetti G; Beccari AR; Pedretti A
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33557115
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Korn SM; Dhamotharan K; Fürtig B; Hengesbach M; Löhr F; Qureshi NS; Richter C; Saxena K; Schwalbe H; Tants JN; Weigand JE; Wöhnert J; Schlundt A
    Biomol NMR Assign; 2020 Oct; 14(2):329-333. PubMed ID: 32770392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsically Disordered Proteins: Perspective on COVID-19 Infection and Drug Discovery.
    Tenchov R; Zhou QA
    ACS Infect Dis; 2022 Mar; 8(3):422-432. PubMed ID: 35196007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jumping from Fragment to Drug via Smart Scaffolds.
    Farahani MD; França TCC; Alapour S; Shahout F; Boulon R; Iddir M; Maddalena M; Ayotte Y; LaPlante SR
    ChemMedChem; 2022 May; 17(10):e202200092. PubMed ID: 35298873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.